About Certadose
Certadose is a company based in Denver (United States) founded in 2013. Certadose has raised $16.23 million across 6 funding rounds. Certadose offers products and services including Certa Dose App, PALS Syringe Holder Kit, Epinephrine Convenience Kit, and Measuring Tape. Certadose operates in a competitive market with competitors including Sensidose, TruMed Systems, INRange Systems, Avancen and ethilog, among others.
- Headquarter Denver, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Certa Dose, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$16.23 M (USD)
in 6 rounds
-
Latest Funding Round
$8.1 M (USD), Series B
Dec 02, 2019
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Certadose
Certadose offers a comprehensive portfolio of products and services, including Certa Dose App, PALS Syringe Holder Kit, Epinephrine Convenience Kit, and Measuring Tape.
App for visualizing and verifying medical doses in emergencies.
Kit for accurate dosing during pediatric emergencies.
Tools for precise epinephrine dosing in anaphylaxis cases.
Device for estimating pediatric weight in medical situations.
Funding Insights of Certadose
Certadose has successfully raised a total of $16.23M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $8.1 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Certadose
Investment portfolio details for Certadose
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Certadose
Detailed financials for Certadose
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Certadose Comparisons
Peer comparison for Certadose
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Certadose
Certadose operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sensidose, TruMed Systems, INRange Systems, Avancen and ethilog, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Individually tailored drug doses are delivered via micro-tablets system.
|
|
| Locked | Locked | Locked |
Vaccine management systems are provided for physician offices and hospitals.
|
|
| Locked | Locked | Locked |
Hardware and software for remote medication management are supplied.
|
|
| Locked | Locked | Locked |
Medication management devices are supplied to hospitals and patients.
|
|
| Locked | Locked | Locked |
Medication dispensing devices are manufactured and supplied by Ethilog.
|
Detailed competitors of Certadose
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Certadose
Complete news archive for Certadose
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Certadose
Certadose was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Certadose is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
Caleb Hernandez is the current CEO of Certadose.
Certadose is a funded company, having raised a total of $16.23M across 6 funding rounds to date.
Certadose is developing a portfolio of products for paediatric care. They have developed colour coded syringes that work in conjunction with the nine colour zones of the Broselow and Hand Tevy methods to eliminate the complex math calculations and provide confidence and color confirmation in pediatric medicine dosing. The syringe has received FDA clearance.
Certadose's top competitors include INRange Systems, TruMed Systems and Sensidose.
Certadose offers Certa Dose App, PALS Syringe Holder Kit, Epinephrine Convenience Kit, and Measuring Tape.